Metizol

Quick links to important sections

Metizol

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Metizol

Metizol: What Type of Medicine is It?

Property Description
Active ingredient Thiamazole (also known as Methimazole)
Form Oral Tablet
Pharmacological class Antithyroid agent / Thioamide derivative
Common purpose Management of Hyperthyroidism
Origin Synthetic compound

Metizol is a prescription-only medication primarily identified as an Antithyroid agent, a class of medicine designated for chemically regulating excessive activity in the thyroid gland. The active ingredient is the synthetic compound known as Thiamazole, which also carries the international non-proprietary name (INN) Methimazole. The primary action of this drug is to serve as a Thyrostatic drug that suppresses the overproduction of thyroid hormones. The drug entity is clinically recognized as a preferred first-line agent for certain patient populations with hyperthyroidism. The drug entity is also recognized on the World Health Organization's List of Essential Medicines, confirming its status as a core component of endocrine therapy.


Composition, Origin, and General Purpose

The core composition features Thiamazole as the single-active ingredient, chemically identified as 1-Methylimidazole-2-thiol. This compound is typically provided as an oral tablet for systemic administration. The formulation is standardized, often marketed to the adult patient group but with specific pediatric guidelines available. The general therapeutic purpose of this Thioamide derivative is to manage health concerns arising from an overactive thyroid, most commonly referred to as hyperthyroidism. By acting as a Thyroid hormone synthesis inhibitor, the medication provides a mechanism to reduce the excessive production of thyroid hormones (T4 and T3) and restore the body's metabolic balance. Thiamazole is also related to Carbimazole, which is a pro-drug that must be converted into Thiamazole to become active, a feature that differentiates Thiamazole as the immediate functional agent.

Regulatory References

  1. Methimazole - LiverTox - NIH
  2. WHO Model List of Essential Medicines, 23rd list, 2023

What side effects are possible with Metizol?

Possible Side Effects and Safety Information

Metizol (Thiamazole/Methimazole) is associated with an official safety profile that defines both common and rare, serious adverse reactions, as documented in regulatory prescribing information.

Adverse Reaction Scope

The most frequently reported adverse reactions are typically mild to moderate and are often classified as Common in regulatory documents. These frequently affect the Skin and Subcutaneous Tissue (e.g., rash, pruritus, urticaria), as well as the Musculoskeletal (arthralgia) and Gastrointestinal systems (nausea, vomiting).

Classification Key Serious Adverse Reactions (Label-Documented)
Uncommon / Rare Agranulocytosis (severe decrease in white blood cells), which is potentially life-threatening and often appears within the first two months of treatment [FDA Label].
Rare Severe Hepatotoxicity (liver injury, including fatal hepatic necrosis), Vasculitis (ANCA-positive), and Lupus-like syndrome [FDA Label].

Safety Constraints and Special Populations

Official regulatory documents include specific safety constraints. Metizol is generally contraindicated in patients with a history of agranulocytosis following thiamazole use, and in those with pre-existing severe hepatic impairment [HPRA SmPC].

Population-Specific Considerations: The drug readily crosses the placental barrier [FDA Label]. Use during the first trimester of pregnancy is associated with a risk of congenital malformations, including aplasia cutis congenita and craniofacial defects [FDA Label, HPRA SmPC]. Consequently, pregnant individuals or those planning pregnancy are subject to specific risk warnings in the labeling.

Regulatory Safety Summary: The documented safety information primarily structures the risk into expected minor effects versus the rare but critical need to monitor Blood and Lymphatic System and Hepatobiliary Disorders. Regular monitoring of blood counts and liver function is noted as necessary by regulatory authorities.

Overdose and Emergency Response

Overdose and When to Seek Help

Metizol (Thiamazole) overdose may be associated with documented clinical manifestations that require urgent attention. Initial signs may include common symptoms such as nausea, vomiting, headache, fever, joint pain, pruritus (itching), and edema (swelling).

Severe Systemic Outcomes

Of critical importance is the risk of delayed, severe systemic toxicity. Overdosage is documented to potentially lead to serious complications, including life-threatening aplastic anemia (pancytopenia) and agranulocytosis, which may manifest hours to days after the event. Other severe outcomes listed in regulatory documents include hepatitis, nephrotic syndrome, exfoliative dermatitis, and effects on the nervous system, such as neuropathies and CNS stimulation or depression.

Mandatory Emergency Intervention

Government sources mandate that individuals seek immediate medical attention for any suspected overdose. Emergency services must be contacted immediately if symptoms involve collapse, seizure, trouble breathing, or unconsciousness. The regulatory label directs contact with the certified Regional Poison Control Center for specialized treatment guidance.

Treatment Principle

Treatment is based on the principle of supportive care. The official prescribing information confirms that no specific antidote is known for Metizol overdose. Management is therefore confined to the initiation of appropriate supportive treatment as determined by the patient's medical status.

Therapeutic Uses of Metizol

Metizol (Thiamazole/Methimazole) is commonly used for managing symptoms related to systemic imbalance and is relevant for easing symptoms that create noticeable physiological strain.

Primary Management of Excessive Thyroid Activity

Metizol is primarily applied in conditions where symptoms may intensify temporarily, including the treatment of Graves' disease and toxic multinodular goiter. It is applicable within clinical settings that involve acute or disruptive symptom patterns and is often used for long-term management. This application assists with maintaining functional stability and may assist in supporting the patient toward a more balanced state.

Relief from Cardiovascular and Hypermetabolic Symptoms

The medication helps ease the distressing symptom burden caused by the body's accelerated metabolism. It is applied in addressing symptom clusters related to heightened physiological activity, such as cardiovascular symptoms (like rapid heart rate and palpitations) and physical agitation (like tremors and nervousness). Additionally, it is applied in addressing symptoms related to physical discomfort, such as unintentional weight loss and constant heat intolerance. This provides support that helps ease the overall symptom burden and contributes to improved day-to-day comfort during symptomatic periods.

Supportive Role in Clinical Stabilization

Metizol is also considered relevant in clinical settings where supportive symptom management is appropriate to prepare for definitive procedures. It is used to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy (surgery) or radioactive iodine therapy. This temporary use may be part of supportive management to prepare for definitive procedures and supports the patient during difficult episodes by easing distress.


Quick Fact: Relief for Systemic Imbalance Metizol is commonly used to help with symptoms related to systemic imbalance, which may assist with maintaining a sense of stability when symptoms are more noticeable.

Eligibility and Restrictions for Use

Who Can and Cannot Use Metizol (Thiamazole/Methimazole)?

Official regulatory guidelines define specific populations for whom Metizol use is strictly prohibited or restricted. This information is derived from government-approved product labeling and is not clinical advice.


Contraindicated and Restricted Populations

Population/Condition Eligibility Status Regulatory Basis
Hypersensitivity Contraindicated Known allergy to Thiamazole or other thioamide derivatives.
Severe Liver Disease Contraindicated Pre-existing severe hepatic insufficiency or failure.
Breastfeeding Women Contraindicated Drug is known to be excreted into human breast milk.
Acute Pancreatitis History Contraindicated Following previous use of Methimazole or Carbimazole.
Severe Blood Disorders Contraindicated Pre-existing agranulocytosis or aplastic anemia.

Conditional and Age-Related Use

Use is restricted during pregnancy, especially in the first trimester, and requires a strict, individualized benefit-risk assessment due to the potential for fetal malformations. The medicine must be discontinued if signs of serious hematological toxicity or severe liver dysfunction occur during treatment. Metizol is generally not recommended for use in children under 2 years of age, though it is approved for older pediatric patients with hyperthyroidism.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Metizol (Thiamazole/Methimazole) primarily documents two distinct domains of interaction patterns with other medicines.

Pharmacodynamic Potentiation

Metizol has a documented anti-vitamin K activity which can potentiate the effects of co-administered oral anticoagulants, such as Warfarin. This pharmacodynamic interaction may increase the activity of the anticoagulant, a pattern strictly noted in official regulatory labeling.

Exposure Modification Due to Thyroid Status Change

A second category of clinically significant interactions is linked to the patient’s transition from a hyperthyroid to a euthyroid state (normal thyroid function) during treatment. This normalization of physiological status can alter the metabolism and reduce the clearance of co-administered medicines, potentially leading to increased exposure to those drugs. This effect is documented in official prescribing information for several classes:

  • Beta-adrenergic Blocking Agents (beta-blockers)
  • Digitalis Glycosides (e.g., Digoxin)
  • Theophylline

Unspecified Interactions

The regulatory profile does not explicitly describe any interactions mediated by CYP enzymes or other drug transporters as the primary basis for these effects. Furthermore, official labeling does not specify any mandatory timing rules for separating administration or any explicit interactions with food, alcohol, or herbal products that alter the drug's safety or efficacy.

Mechanism of Action

Metizol ( Methimazole) functions by selectively concentrating in the thyroid gland to interfere directly with the synthesis of thyroid hormones. Its primary mechanism is the inhibition of the enzyme thyroid peroxidase (TPO), located within the thyroid follicular cells. TPO is essential for the initial steps of hormone production. By blocking TPO, Metizol prevents the necessary chemical reactions, specifically the iodination of tyrosine residues and the subsequent coupling of monoiodotyrosine (MIT) and diiodotyrosine (DIT) to form active T4 and T3. This mechanistic interference modifies the early molecular steps of the hormone production cascade. This upstream blockade results in a gradual reduction in the concentration of active T4 and T3 mediators circulating systemically as pre-existing stores are cleared. This limitation of hormone pool replenishment restricts the degree of humoral signaling, affecting the intensity of downstream physiological responses.

Dosage and Administration Information

How Metizol is Used

Metizol (Thiamazole/Methimazole) administration follows a protocol involving an initial high-dose phase followed by a long-term maintenance regimen.


Official Administration Guidelines

Parameter Instruction
Route of Administration The approved route is oral ingestion as a tablet.
Dosing Schedule (Adults) Initial Dosing typically ranges from 15 mg to 60 mg daily, determined by the severity of the condition. Maintenance Dosing is generally 5 mg to 15 mg daily.
Frequency Pattern The initial total daily dose is typically administered in three equally divided doses at 8-hour intervals. The maintenance dose may transition to a single daily dose.
Pediatric Dosing Rule Initial dosage is based on body weight, starting at 0.4 mg/kg per day, divided into three doses, not to exceed 30 mg daily.

Procedural Structure and Course Duration

The usage protocol is characterized by a titration logic. The initial high dosage is maintained until the patient achieves a euthyroid state (metabolic balance). Following this stabilization, the dose is titrated (reduced) to the lower maintenance range. The overall therapy is considered long-term, typically continuing for at least six months and often for up to eighteen months.

Missed Dose Guidance

If a dose is missed, it is generally recommended to take it as soon as possible, unless it is almost time for the next scheduled dose, in which case the missed dose is skipped to avoid taking a double dose. The medication is not required to be taken with food, but consistent timing is emphasized.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Metizol

Evidence for Use in Managing Graves' Disease (Hyperthyroidism)

Research exploring the use of Metizol (Thiamazole/Methimazole) includes many Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies monitor key outcomes related to functional imbalance, primarily the achievement and maintenance of euthyroidism (normalized thyroid hormone levels). Trials monitor the frequency of relapse after therapy, which typically runs 18 to 24 months. Findings describe patterns where hormone levels were measured within the euthyroid range during the study period. What remains uncertain is the reliable prediction of long-term, sustained euthyroidism after the medication is discontinued, as definitions and follow-up protocols vary across studies.

Evidence for Use in Managing Toxic Multinodular Goiter

The evidence base for toxic multinodular goiter (TMNG) relies primarily on long-term observational cohorts and clinical trials. These studies explored outcomes related to physical discomfort and systemic stability, monitoring patients for maintenance of normal hormone levels over many years. Studies report patterns where patients were monitored in a euthyroid state for specific periods. Comparative evidence with definitive treatments, such as surgery or Radioactive Iodine, is limited from large-scale RCTs in this specific context.

Evidence for Pre-Procedure Preparation (Surgery and Radioiodine)

Metizol was studied for its relevance in trials assessing symptom patterns in patients preparing for thyroidectomy or Radioactive Iodine (RAI) therapy. Studies monitored the critical outcome of achieving a euthyroid state before the procedure. Research explored the relationship between pre-procedure hormone status and the occurrence of certain perioperative events. Certainty remains low regarding the ideal duration of therapy or the role of specific adjunctive agents when used alongside Metizol right before a procedure.

Research in Specific Patient Groups

Research has explored the use of Metizol in patient populations outside the main adult cohort, including studies focused on pediatric patients. Data for other groups remain insufficient. For example, evidence exploring the long-term patterns of stability for older adults with multiple co-existing health conditions is often modest, meaning research results apply primarily to the populations specifically studied in the trials.

Key Studies & References

  1. Methimazole Tablets, USP - DailyMed (FDA-approved labeling)
  2. Efficacy of methimazole before the administration of radioactive iodine in the management of Graves' disease: a systematic review and meta-analysis
  3. Methimazole - eEML (WHO Electronic Essential Medicines List) Listing
  4. Long-Term Treatment with Antithyroid Drugs: Efficacy and Safety

Frequently Asked Questions (FAQ)

Common questions about Metizol (FAQ)

Q: What is the main reason Metizol is prescribed?

According to the official product information, Metizol is indicated primarily for treating hyperthyroidism, which is when the thyroid gland is overactive. The medication is also indicated for preparing patients for certain medical procedures, such as thyroid surgery or radioactive iodine therapy.

Q: Is Metizol used for conditions other than the primary one mentioned?

Regulatory documents indicate that its use is limited to the management of hyperthyroidism and for specific pre-treatment preparation before medical procedures. Official labeling does not typically list other indications.

Q: How quickly do people generally expect to feel a difference after starting Metizol?

Studies and official information indicate that it usually takes a few weeks to a couple of months before thyroid hormone levels begin to improve noticeably. The treatment works toward achieving a euthyroid state (normal metabolic balance), which is generally a gradual process.

Q: Is Metizol known to cause weight gain?

Official warnings mention that a change in weight, specifically weight gain, may occur. This can happen if the medication causes a transition into hypothyroidism (low thyroid levels), as weight change is often a symptom of that condition.

Q: Can Metizol affect sleep patterns?

Regulatory resources list drowsiness as a possible side effect of Metizol. If changes in sleep patterns or fatigue occur, it is recommended to discuss this with a healthcare provider.

Q: What are the most common side effects reported with Metizol?

According to official product information, the most common side effects reported are generally mild and can include skin rash, itching, stomach upset, nausea, vomiting, headache, and drowsiness.

Q: Are there any long-term side effects associated with Metizol use?

Official documents list potential serious effects associated with long-term use, such as liver damage (hepatotoxicity) and inflammation of the blood vessels (vasculitis). Long-term therapy typically involves monitoring for these risks, as well as for the development of hypothyroidism.

Q: Does Metizol interact with common over-the-counter pain relievers?

Official sources advise that Metizol can interact with certain other drug classes, such as oral anticoagulants. Regulatory sources recommend disclosing all medicines, including over-the-counter pain relievers, to a healthcare provider to ensure interaction checks can be performed.

Q: Is Metizol the same kind of medication as [similar drug name]?

Metizol, known scientifically as Methimazole, belongs to the class of medications called thionamides or antithyroid agents. This class contains drugs that all work by interfering with the synthesis of thyroid hormones.

Q: How does Metizol's mechanism differ from other drugs in its class?

Like other agents in its class, Metizol works by inhibiting thyroid peroxidase, a key enzyme for hormone production. Regulatory-based descriptions note that Metizol is considered to be more potent on a weight-by-weight basis than propylthiouracil (PTU), another antithyroid agent.

Q: Is Metizol considered a 'strong' medicine?

Regulatory information provides a factual basis for the drug's activity, noting that Metizol is considered to be 10 times more potent on a weight basis compared to propylthiouracil (PTU), another medication in the same drug class.

Q: Are there any specific food restrictions to be aware of when using Metizol?

While Metizol is generally not required to be taken with food, official information suggests that monitoring overall iodine intake may be important, as excessive amounts can potentially interfere with the effectiveness of the treatment.

Q: Can older adults safely use Metizol?

Official documents do not list a specific age restriction for older adults. However, the official warnings emphasize the need for caution in all patients who have pre-existing conditions, particularly liver or kidney disease, which are often factors that require careful management.

Q: Is Metizol safe to use during pregnancy (as described in official documents)?

Official warnings state that Metizol crosses the placenta and can cause fetal harm, especially when administered during the first trimester of pregnancy. Official guidance suggests that when the medication is necessary during this time, the lowest effective dose should be considered.

Q: What are the restrictions on Metizol use for people with liver issues?

The use of Metizol is associated with a risk of liver toxicity, a condition called hepatotoxicity. Liver disease requires caution and monitoring, and official guidance indicates that if evidence of significant liver abnormality is observed, the drug should be promptly discontinued under medical supervision.

Q: Are there any known interactions between Metizol and herbal supplements?

Regulatory guidance recommends disclosing all prescription, non-prescription medicines, and supplements to a healthcare provider. Official guidance specifically advises providers to be informed about all herbal products due to the potential for interaction.

Q: Is it common to experience dizziness when first starting Metizol?

According to official product information, dizziness is listed as a reported side effect of Metizol. If this symptom is severe or persistent, medical guidance should be sought.

Q: Do studies suggest Metizol is effective for its main indicated use?

The official status of Metizol as an FDA-approved and indicated treatment for hyperthyroidism confirms the existence of supportive clinical evidence. This approval indicates the drug has been shown to be effective in reducing the production of thyroid hormones.

Q: What is the difference between generic Metizol and the brand-name version?

Generic Metizol (methimazole) is required by regulatory agencies to have the same active ingredient and function in the body in the same way as the brand-name version (Tapazole). This means that both forms are expected to deliver the same clinical effect and safety profile.

Q: What should I do if a side effect of Metizol feels severe?

Official guidance states that immediate medical attention should be sought, such as calling a doctor or emergency services, if severe symptoms occur. These include signs of serious reactions like a sore throat, fever, unusual bleeding or bruising, or symptoms that suggest liver problems.

Q: Are there different strengths of Metizol available?

Official drug information lists Metizol (Methimazole) as being typically available in tablet strengths of 5 mg and 10 mg. The determination of the appropriate strength and dose is managed by a healthcare provider.

Q: Can Metizol cause mood changes or depression?

Regulatory warnings note that depressed mood is a potential symptom of hypothyroidism, the condition of having too little thyroid hormone. Since Metizol works to reduce thyroid hormone production, it can potentially cause hypothyroidism if hormone levels drop too low.

Q: Is it normal to feel tired after taking Metizol?

Official resources list unusual tiredness or fatigue as a reported side effect of Metizol use. Fatigue is also a common symptom of hypothyroidism, which the drug may cause if hormone levels drop too low.

Q: Does Metizol affect blood sugar levels?

Official adverse event reporting has included signs of low blood sugar, known medically as hypoglycemia, in association with this medication. The occurrence of changes in blood sugar suggests that monitoring may be needed.

Q: What conditions make a person ineligible to use Metizol?

According to the official product information, Metizol is contraindicated (should not be used) in individuals with a known hypersensitivity or allergic reaction to Metizol itself or any of its inactive ingredients. Other specific contraindications, such as certain blood disorders or liver disease, are noted.

Q: What scientific evidence supports the use of Metizol?

The use of Metizol is supported by the clinical and non-clinical evidence required by regulatory bodies to grant official approval and an indication (authorized use) for the treatment of hyperthyroidism.

Q: Are there common user misunderstandings about how Metizol works?

Official information clarifies that while the drug stops hormone synthesis, it does not address the underlying cause of the hyperthyroidism (such as an autoimmune disorder). This is because the mechanism is based on inhibiting thyroid peroxidase to prevent new hormone formation.

Q: Does Metizol cause headaches?

Regulatory resources list headache as one of the commonly reported side effects associated with the use of Metizol.

Q: Does Metizol have a black box warning in the US (FDA)?

According to the US Food and Drug Administration (FDA) labeling, Metizol (Methimazole) does not currently carry a Black Box Warning. This type of warning is reserved for highlighting the most serious safety risks for certain medications.

Q: Can Metizol affect the results of lab tests?

Yes, official information states that Metizol itself is monitored using thyroid function tests (TFTs). Additionally, certain supplements, such as high-dose Biotin (Vitamin B7), are known to interfere with the accuracy of these lab test results.

Q: Is Metizol safe for people with kidney problems?

Official labeling lists kidney disease or problems as conditions that require Metizol to be used with caution. Such conditions may necessitate increased monitoring.

Q: What is the official classification or drug class of Metizol?

Metizol is officially classified by regulatory and chemical bodies as a thionamide or an antithyroid agent. These terms refer to the specific class of medication that works by acting on the thyroid gland.

Q: Why do some people need to avoid Metizol?

People must avoid Metizol if they have a confirmed hypersensitivity (allergic reaction) to the drug itself or to any of its components. Other specific contraindications, such as certain blood disorders or liver disease, are noted.

Q: Are there specific age limits for using Metizol?

The official product information includes specific pediatric dosing rules for children, based on body weight. This confirms that the drug is approved for use in younger patients, though a healthcare provider assesses appropriateness based on individual factors, including age and weight.

Q: What is the risk profile of Metizol compared to similar drugs?

Regulatory information suggests the risk of serious liver toxicity (hepatotoxicity) may be lower with Metizol than with propylthiouracil (PTU). This difference in risk is often a factor considered by prescribers, particularly when the drug is used in children.

Q: What are the signs of a possible allergic reaction to Metizol?

Official safety information lists signs of a severe allergic reaction, which include the rapid appearance of hives or rash, itching, and swelling of the face, tongue, or throat. The experience of trouble breathing or other severe symptoms warrants immediate medical attention.

Q: What are the official clinical expectations for people using Metizol?

The main official clinical expectation for people using Metizol is achieving and maintaining a euthyroid state, which means normal thyroid function. This therapeutic goal often requires adjusting the initial dose over time (titrating) and requires the patient to commit to long-term therapy.

Q: How do drug regulators describe the safety of Metizol?

Regulators describe the safety of Metizol by providing serious warnings in the official labeling. These include the risks of severe complications like agranulocytosis (a dangerous drop in white blood cells) and liver injury. There is also a warning about potential fetal harm if used in early pregnancy.

Q: Does Metizol have a common side effect of nausea?

Yes, official product information lists both nausea and vomiting as commonly reported side effects associated with Metizol use.

Q: Do research studies show Metizol losing effectiveness over time?

Regulatory documents describe the long-term nature of the treatment, which typically lasts 12 to 18 months. The usage protocol involves adjusting the dose from an initial high level to a lower maintenance dose to maintain effectiveness once the patient achieves stable hormone levels.

Q: Is Metizol known to cause stomach upset?

Yes, official safety resources list upset stomach and stomach pain as commonly reported gastrointestinal side effects associated with Metizol.

Q: What patient monitoring is required during Metizol treatment?

Close surveillance is typically involved, which includes monitoring Thyroid Function Tests (TFTs). Immediate evaluation of white blood cell counts and liver function is indicated if symptoms of illness occur.

Q: What are the key safety facts about Metizol?

Key safety facts from regulatory sources include the potential for serious adverse events such as agranulocytosis (a serious blood disorder) and liver injury (hepatotoxicity). There is also an important warning about the risk of fetal harm if the drug is used during the first trimester of pregnancy.

How should Metizol be stored and disposed of?

How to Store and Dispose of Metizol (Thiamazole/Methimazole)

Storage and disposal of Metizol oral tablets must adhere strictly to regulatory requirements to maintain product stability and ensure safety.


Storage Conditions

The tablets must be stored at controlled room temperature, specifically between 20°C and 25°C (68°F to 77°F), with excursions permitted up to 30 C (86 F). The product must be protected from moisture and kept in a tight, light-resistant container. Always store this medication out of the reach of children.


Disposal Instructions

Unused or expired Metizol should be discarded using a drug take-back program if one is available. If not, dispose of the tablets in household trash after mixing them with an unappealing substance, like coffee grounds, and placing the mixture in a sealed container. Do not flush Metizol down a toilet or drain unless instructed to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Metizol found in:

A-Z Index: